ALXN
Alexion Pharmaceuticals Inc
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
586 hedge funds and large institutions have $25.3B invested in Alexion Pharmaceuticals Inc in 2017 Q4 according to their latest regulatory filings, with 91 funds opening new positions, 225 increasing their positions, 209 reducing their positions, and 95 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
586
Holders Change
-9
Holders Change %
-1.51%
% of All Funds
13.31%
Holding in Top 10
17
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-10.53%
% of All Funds
0.39%
New
91
Increased
225
Reduced
209
Closed
95
Calls
$420M
Puts
$468M
Net Calls
-$48.2M
Net Calls Change
-$165M
Top Buyers
Top Sellers
| 1 |
1
BlackRock
New York
|
$2.15B |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$2.11B |
| 3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$2.51B |
| 4 |
TP
4
Third Point
New York
|
$0 |
| 5 |
TCP
5
Tourbillon Capital Partners
New York
|
$71.6M |
